| |
|
|
 |
|
 |
|
|
|
The Reliance
Group is India’s largest private sector enterprise, with annual revenues of US$ 58 billion. The Group’s activities span oil and gas exploration and production, petroleum refining, petrochemicals, polyester, plastics, organized retailing and telecom. The Group’s flagship company Reliance
Industries Limited is the largest private sector company and a Fortune Global 500 company. The Reliance group has a market capitalization of US$ 75 billion.
Reliance Life Sciences (RLS) is part of the Reliance Group of companies. RLS was established to develop business opportunities in medical, plant and industrial biotechnology; with key initiatives in biopharmaceuticals, pharmaceuticals, regenerative medicine, clinical research, molecular diagnostics, plant and industrial biotechnology.
Reliance Life Sciences is developing business
opportunities in the domains of medical,
plant and industrial biotechnology.
From a domain perspective, these opportunities
cover:
| a. |
Biopharmaceuticals (Plasma Proteins,
Biosimilars (Recombinant Proteins,
Monoclonal Antibodies) and Novel Proteins) |
| b. |
Pharmaceuticals (Oncology, Steroid,
Hormone and Peptide - Active Pharmaceutical
Ingredients and Formulations ) |
| c. |
Clinical Research Services (Pre-clinical
animal studies, Bioavailability and
Bioequivalence studies, Phase 1 studies,
Phase 2 to 4 studies, QTc studies,
Mass balance/Micro dosing studies,
Clinical Data Management, Biostatistics,
Clinical Trial Supplies Management,
Medical Writing, Pharmacovigliance,
Regulatory Services and Quality Assurance
) |
| d. |
Regenerative Medicine (Stem Cell
therapies, Tissue Engineered products,
Stem Cell enriched Repository Services,
Assisted Reproduction and Fetal Medicine)
|
| e. |
Molecular Medicine (DNA/RNA-based
diagnostics, Molecular Genetics, Predictive
Diagnostics, Histopathology, Cytopathology,
Flow Cytometry based diagnosis, Pharmacogenomics) |
| f. |
Novel Therapeutics (siRNA Therapies) |
| g. |
Biofuels (Biodiesel, Bioethanol,
Biobutanol) |
| h. |
Plant Tissue Culture |
| i. |
Industrial Biotechnology (Biopolymers,
Biochemicals, Enzymology) |
From an integration perspective, these
opportunities encompass Repositories,
Research, Process Development, Pre-clinical
Studies, Human Clinical Trials, Commercial-scale
Manufacture and Marketing, all of which
are carried out in-house.
Reliance GeneMedix plc, a UK-based subsidiary
of Reliance Life Sciences with a manufacturing
facility in Ireland, is developing biosimilars
for the European market.
Reliance Institute of Life Sciences is
a not-for-profit organisation, focusing
on competency development in Biotechnology,
not only for Reliance Life Sciences but
also for the industry. The Institute offers
a wide range of competency development
programs and diploma programs in Biotherapeutics
and Clinical Research.
Reliance Life Sciences initiative is one
of the most diverse and integrated biotechnology
initiatives being developed anywhere in
the world.
Consistent with the diversity and depth
of its initiatives, Reliance Life Sciences
has a professional team comprising substantially
of Ph. Ds, M.Ds, Engineers and Post Graduates
in Science. The average age of the Reliance Life Sciences team is 33 years. 28% of the employees are women.
RLS operates state-of-the-art facilities in the life sciences domain. The flagship facility is the Dhirubhai Ambani Life Sciences Centre (DALC) in Navi Mumbai. Spread over 20 acres, DALC is among the most diverse and integrated life sciences campuses in the world. Its diversity stems from the wide spectrum of areas of research and development undertaken and its integration comes from repository, laboratory research, pre-clinical research, clinical research and manufacturing facilities; all located in the same campus. A second facility is in Bangalore, for clinical pharmacology and clinical data management.
Today RLS is a fully-integrated life sciences industry player with in-house capabilities in research, pre-clinical and clinical development, process development, commercial-scale manufacturing, marketing and local sales organization. The Company employs about 800 people, many of whom have PhDs or post-graduate degrees.
|
|
|
|
|
|
|
|
|
|
|
